Elsevier Inc.

SHERPA: Unknown

People

  1. Shah
    Shah
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Scordo
    Scordo
  5. Devlin
    Devlin
  6. Dahi
    Dahi
  7. Tamari
    Tamari
  8. Gyurkocza
    Gyurkocza
  9. Jakubowski
    Jakubowski
  10. Landau
    Landau

Groups

  1. Bone Marrow Transplant (73)
  2. Center for Hematologic Malignancies (73)
  3. Department of Medicine (73)
  4. Hematologic Malignancies, Division of (73)
  5. Survivorship Research (73)
  6. CTCR Scholars (55)
  7. MSK Grad Students (47)
  8. Master of Science in Clinical and Translational Cancer Research (47)
  9. DigITs Research Group (45)
  10. Epidemiology and Biostatistics (44)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Biology of Blood and Marrow Transplantation"
  3. "Gunjan Shah"
Formats
  1. Meeting Abstract (57)
  2. Journal Article (15)
  3. Review (1)
Groups
  1. Bone Marrow Transplant (73)
  2. Center for Hematologic Malignancies (73)
  3. Department of Medicine (73)
  4. Hematologic Malignancies, Division of (73)
  5. Survivorship Research (73)
  6. CTCR Scholars (55)

More Groups

People
  1. Gunjan Shah (73)
  2. Sergio Giralt (63)
  3. Miguel-Angel Perales (47)
  4. Michael Scordo (45)
  5. Molly Maloy (45)
  6. Sean Devlin (43)

More People

Years
  1. 2020 (21)
  2. 2019 (16)
  3. 2018 (21)
  4. 2017 (9)
  5. 2016 (2)
  6. 2015 (4)
Publications
  1. Biology of Blood and Marrow Transplantation (73)

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors for postrelapse survival after ex vivo CD34(+)-selected (T cell-depleted) allogeneic hematopoietic cell transplantation in multiple myeloma
    Journal Article

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Scordo, M.; Ruiz, J. D.; Bryant, A.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Infectious complications in aggressive B cell non-Hodgkin lymphoma after CD-19 chimeric antigen receptor T cell therapy
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Maloy, M. A.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Sauter, C. S.; Batlevi, C. W.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of toxicities on outcomes for aggressive B cell non-Hodgkin lymphoma patients after CD19-directed chimeric antigen receptor T cell: Real-world experience
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Flynn, J.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. W.; Shah, G. L.; Scordo, M.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Effect of melphalan exposure in patients with lymphoma undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Lin, A.; Dahi, P. B.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; DeRespiris, L.; Figgins, B.; Griffin, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of and decreased inpatient hospital days for non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) patients with outpatient BEAM using daily etoposide and cytarabine and autologous hematopoietic stem cell transplantation (AHCT)
    Meeting Abstract

    Cavalier, K.; Cazeau, N.; Bhatt, V.; McElrath, C.; LeStrange, N. J.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of conditioning regimens for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K. T.; Lin, A.; Ruiz, J. D.; Zheng, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Sauter, C. S.; Perales, M.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save